)
)
Carmat Investor Relations Material
Latest events
Trading Update
Carmat
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Carmat SA
Access all reports
Carmat SA is a French medical technology company that specializes in the development and manufacturing of advanced artificial heart systems. The company's flagship product is the Aeson, a biocompatible, fully implantable total artificial heart designed to provide a life-saving alternative for patients suffering from end-stage biventricular heart failure. Carmat's innovative heart prosthesis mimics the natural human heart's functions and aims to bridge the gap for patients awaiting heart transplants. Carmat SA is headquartered in Vélizy-Villacoublay, France, and its shares are listed on the Euronext Paris.
Key slides for Carmat SA
Trading Update
Carmat SA
H2 2023
Carmat SA
Latest articles
)
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
)
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
)
Irwin Jacobs & Andrew Viterbi: Qualcomm's Pioneering Founders
In 1985, Irwin Jacobs and Andrew Viterbi co-founded Qualcomm, a leading company in telecommunications and semiconductor innovation.
3 Oct 2024
Ticker symbol
ALCAR
Country
🇫🇷 France